Verder Group Acquires ERWEKA
The Verder Group is proud to announce the successful acquisition of ERWEKA, a highly regarded German company
renowned for its development and manufacturing of premium tablet testing equipment.
With this acquisition the Verder Scientific division further strengthens its position and accelerates the growth trajectory
in targeted niche markets with high state-of-the-art equipment.
ERWEKA, founded in 1951, has a manufacturing
and assembly facility in Langen, near Frankfurt,
and sales offices in the US and Hong Kong. The
company supplies dissolution and tablet testing
equipment for pharmaceutical and life science
companies, research and test laboratories,
and universities all over the world. With its
complementary technology to Verder Scientific,
this acquisition is an opportunity to increase our
market share.
Commenting on the acquisition, Andries Verder,
CEO Verder Group, expressed enthusiasm for
the opportunities it presents: "We are excited
to welcome ERWEKA into the Verder family.
Their strong market position and exceptional expertise perfectly complement the Verder Scientific existing portfolio.
Together, we will unlock new possibilities, accelerate innovation, and create synergies that benefit our customers,
employees, and stakeholders."
Claudia Müller, CEO ERWEKA, states: “Today marks an exciting milestone as our technology driven company joins forces
with Verder Scientific. Together, we embark on a journey that not only guarantees a future-proof and robust foundation
but also unveils unprecedented growth possibilities. Our shared vision is rooted in the belief that technology, when
harnessed strategically, can transform lives and businesses alike."
ERWEKA will become an integral part of Verder´s Scientific
Instruments Division, whose CEO, Dr. Jürgen Pankratz,
stated: “We will take our time to deeply understand the
customers needs and dynamics of this new business
segment. I have no doubt that subsequently we will
jointly derive a business plan that will make significant
contributions to the future growth and success of
ERWEKA.”
